Capstone Investment Advisors
GH icon

Capstone Investment Advisors’s Guardant Health GH Stock Holding History

Capstone Investment Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,500
Closed -$988K – 1702
2022
Q2 		$988K Hold
24,500
– – ﹤0.01% 1017
2022
Q1 		$1.62M Buy
+24,500
New +$1.68M ﹤0.01% 1148

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capstone Investment Advisors's GH Position: Q2 2026 in Review

Capstone Investment Advisors opened a new position in Guardant Health (GH) in Q2 2026: 1,691 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #1534 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in GH as recently as Q4 2025.

Capstone Investment Advisors first reported a position in GH in Q1 2022 and has held it in 7 quarters since. The position peaked at $2.36M in Q3 2025. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Capstone Investment Advisors held 1,691 shares of Guardant Health worth $254K as of Q2 2026.
  • Guardant Health was a new Capstone Investment Advisors position in Q2 2026.
  • Guardant Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1534 holding.
  • Capstone Investment Advisors first reported a position in Guardant Health in Q1 2022 and has held it in 7 quarters since.
  • Capstone Investment Advisors's Guardant Health position peaked at $2.36M in Q3 2025.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.